These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1743981)

  • 21. Neuroimaging in pediatric epilepsy.
    Kuzniecky RI
    Epilepsia; 1996; 37 Suppl 1():S10-21. PubMed ID: 8647047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introduction to the conference. Positron emission tomography.
    Wagner HN
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):S2-6. PubMed ID: 2535417
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical applications of positron emission tomography.
    Maisey M; Jeffery P
    Br J Clin Pract; 1991; 45(4):265-72. PubMed ID: 1810361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [PET in clinical work. A refined instrument for imaging].
    Långström B; Bergström K; Bergström M; Valind S
    Lakartidningen; 1995 Sep; 92(36):3203-13. PubMed ID: 7674712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain perfusion SPET and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations.
    Colamussi P; Trotta F; Ricci R; Cittanti C; Govoni M; Barbarella G; Giganti M; Bajocchi G; Uccelli L; Trevisan C; Piffanelli A
    Nucl Med Commun; 1997 Mar; 18(3):269-73. PubMed ID: 9106782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands.
    Kegeles LS; Mann JJ
    Neuropsychopharmacology; 1997 Nov; 17(5):293-307. PubMed ID: 9348545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychiatric disorders: investigation of schizophrenia and substance abuse.
    Volkow ND; Fowler JS
    Semin Nucl Med; 1992 Oct; 22(4):254-67. PubMed ID: 1439871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission tomography in the investigation of central nervous system disorders.
    Jamieson D; Alavi A; Jolles P; Chawluk J; Reivich M
    Radiol Clin North Am; 1988 Sep; 26(5):1075-88. PubMed ID: 3047777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of fluorodeoxyglucose PET in the diagnosis of central nervous system lupus erythematosus and a comparison with CT and MRI].
    Stoppe G; Wildhagen K; Meyer GJ; Schober O
    Nuklearmedizin; 1989 Oct; 28(5):187-92. PubMed ID: 2813082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders.
    Hesse S; Barthel H; Schwarz J; Sabri O; Müller U
    Neurosci Biobehav Rev; 2004 Oct; 28(6):547-63. PubMed ID: 15527862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging in neurologic diseases--comparison with computed tomography.
    Chang KH; Han MC; Kim CW
    J Korean Med Sci; 1987 Mar; 2(1):53-63. PubMed ID: 3269244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.
    Atri A
    Handb Clin Neurol; 2016; 136():971-84. PubMed ID: 27430453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on PET imaging biomarkers in the diagnosis of neuropsychiatric disorders.
    Hellwig S; Domschke K
    Curr Opin Neurol; 2019 Aug; 32(4):539-547. PubMed ID: 31083013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computerized tomography, magnetic resonance imaging, and positron emission tomography in the study of brain trauma. Preliminary observations.
    Langfitt TW; Obrist WD; Alavi A; Grossman RI; Zimmerman R; Jaggi J; Uzzell B; Reivich M; Patton DR
    J Neurosurg; 1986 May; 64(5):760-7. PubMed ID: 3486260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain imaging in dementia of the Alzheimer type.
    Faulstich ME
    Int J Neurosci; 1991 Mar; 57(1-2):39-49. PubMed ID: 1938155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography.
    Shagam JY
    Radiol Technol; 2001; 72(6):551-69; quiz 570-2. PubMed ID: 11480335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. I-123 Iofetamine SPECT scan in children with neurological disorders.
    Flamini JR; Konkol RJ; Wells RG; Sty JR
    Wis Med J; 1990 Oct; 89(10):584-7. PubMed ID: 2238681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New trends in developmental neuroimaging in psychiatry.
    Keshavan MS; Rosenberg DR
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 May; 23(4):557-60. PubMed ID: 10390715
    [No Abstract]   [Full Text] [Related]  

  • 40. Advances in neurology (1).
    Gilman S
    N Engl J Med; 1992 Jun; 326(24):1608-16. PubMed ID: 1584262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.